Taylor Farms Creamy Homestyle Coleslaw Kit, dressing included. Green Cabbage, Carrots, Red Cabbage and Creamy coleslaw dressing. Triple...
⚠ Critical Alert — Stop Using Immediately
This product has been flagged with severe risks (undeclared allergen). Stop using it now and contact the brand or FDA for a refund, repair, or replacement.
FDA Recall Notice
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-3457-2017.
One production lot of Creamy Homestyle Coleslaw kit was inadvertently packed with organic dressing packet which contains egg and milk. Only egg is declared on product labeling.
Corrective Action (per FDA)
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-3457-2017.
Recall terminated by FDA.
✅ What you should do
- Stop using the product if you own it.
- Check the model number, lot code, or sell-by date against the recall notice above.
- Contact Taylor Farms Retail, Inc. or the retailer where you bought it for a refund, replacement, or repair.
- For the most current official instructions, visit the FDA recall page.
- If you've been hurt by this product, report the incident to FDA.
Consumer Contact (per FDA)
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-3457-2017.
Taylor Farms Retail, Inc.
About the U.S. Food and Drug Administration
The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.
Visit FDA.gov →📣 Report a food, supplement, or cosmetic problem to the FDA
If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.
Taylor Farms Retail, Inc. Recall FAQ
Taylor Farms Retail, Inc. is the subject of a produce safety report: Taylor Farms Creamy Homestyle Coleslaw Kit, dressing included. Green Cabbage, Carrots, Red Cabbage and Creamy coleslaw dressing. Triple.... The notice was published on August 7, 2017 by the U.S. Food and Drug Administration (FDA). Approximately 293 units are potentially affected.